Saxagliptin is a DPP-4 inhibitor used to control blood sugar levels in patients with type 2 diabetes.
Saxagliptin belongs to a class of medicines called DPP-4 inhibitors. It helps control blood sugar levels in people with type 2 diabetes. This active ingredient is found in the combination tablet Kombiglyze XR, which also contains metformin.
In Hong Kong, the main product that includes saxagliptin is Kombiglyze XR. It is an extended-release tablet that combines saxagliptin with metformin in a single pill. The tablet is available in several strengths, such as 2.5 mg/500 mg and 5 mg/1000 mg of the two ingredients. Both the brand name and the generic version are marketed by the same manufacturer, and the product is listed on the Hong Kong Department of Health’s register of approved medicines.
People with type 2 diabetes often take saxagliptin together with other drugs, such as metformin, to achieve better overall control of their glucose levels. The medication is intended for adults who have been diagnosed with this chronic condition.
Saxagliptin blocks an enzyme called DPP-4, which normally breaks down hormones that raise insulin after a meal. By inhibiting this enzyme, the drug allows those hormones to stay active longer, prompting the pancreas to release more insulin when needed and to lower blood sugar naturally. The effect starts within a few days of regular use and helps maintain steadier glucose levels throughout the day.
Most people experience only mild and short-lasting effects, such as:
These symptoms usually improve on their own and do not require medical intervention unless they persist.
Although rare, some reactions need urgent attention:
If any of these occur, immediate medical help should be sought.
Certain groups should discuss saxagliptin use with a qualified healthcare professional before starting treatment:
A thorough review of personal health history can help determine if saxagliptin is appropriate.
Saxagliptin can interact with other medicines and lifestyle factors:
For a complete list of possible interactions, refer to the specific medication’s information sheet.
Store Kombiglyze XR tablets at room temperature, away from moisture and direct sunlight. The medication is usually taken once daily, but the exact schedule depends on the strength and formulation prescribed. Because the tablet comes in different combinations, always follow the directions printed on the product label. For details on dosing, administration, or any special instructions, consult the individual medication’s leaflets.
DPP-4 inhibitor: A drug that blocks the enzyme dipeptidyl peptidase-4, helping the body release more insulin after meals.
Extended-release: A formulation designed to release the medicine slowly over time, allowing once-daily dosing.
Hyperglycaemia: Higher than normal blood sugar levels, often seen after eating or in uncontrolled diabetes.
This article provides general educational information about saxagliptin as an active ingredient used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing saxagliptin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
